Autolus Therapeutics plc
AUTL
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Autolus Therapeutics plc, biofarmaceutická společnost v klinickém stadiu, vyvíjí T-buněčné terapie pro léčbu rakoviny. Programy společnosti v klinickém stádiu zahrnují obecabtagenní autoleucel (AUTO1), programovou T-buněčnou hodnotící terapii zaměřenou na CD19, která je v klinické studii fáze 1b/2 pro léčbu dospělých ALL; AUTO1/22, která je ve fázi 1 klinické studie u pediatrických pacientů s relabující nebo refrakterní ALL; AUTO4, programovou T-buněčnou hodnotící terapii pro léčbu periferního T-buněčného lymfomu zaměřeného na TRBC1; AUTO6NG, programovou T-buněčnou hodnotící terapii, která je v preklinické fázi zaměřená na GD2 ve vývoji pro léčbu neuroblastomu; a AUTO8, přípravek kandidující na léčbu mnohočetného myelomu ve fázi I klinické studie. Zaměřuje se také na vývoj AUTO5, hematologického produktu, který je v předklinickém vývoji. Společnost byla založena v roce 2014 a má sídlo v Londýně ve Spojeném království.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
647
Založení
2018-06-22
Podobné společnosti
$ 1.61
+ $ 0.03
$ 3.15
- $ 0.03
$ 28.44
- $ 0.42
$ 3.00
+ $ 0.12
$ 5.45
+ $ 0.10
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 75.4 | 75.6 | 10.1 | 1.7 | 6.2 | 2.3 | 0.2 | 2.9 | 1.0 | 1.7 | 1.2 | |
| Cost of Revenues | 96.3 | 96.4 | 141.0 | 6.6 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 0.0 | 0.0 | |
| Gross Profit | -21.0 | -21.0 | -130.9 | -4.9 | 6.2 | 2.3 | 0.2 | 2.9 | 1.4 | 1.7 | 1.2 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 24.3 | 21.2 | 20.9 | 9.0 | 0.0 | 0.0 | 0.0 | 10.1 | 1.8 | 0.4 | |
| Cost of Revenues | 25.3 | 28.6 | 24.4 | 18.0 | 138.3 | 1.2 | 0.0 | 1.8 | 1.8 | 0.4 | |
| Gross Profit | -1.0 | -7.4 | -3.5 | -9.0 | -138.3 | -1.2 | 0.0 | 8.3 | 0.0 | 0.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 150.0 | 142.0 | 134.8 | 134.9 | 105.4 | 24.6 | 16.0 | 10.4 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 46.7 | 31.9 | 31.9 | 35.0 | 39.5 | 16.8 | 9.1 | 5.2 | |
| Depreciation & Amortization | 10.0 | 9.8 | 7.7 | 6.6 | 7.4 | 8.5 | 5.7 | 4.6 | 1.1 | 1.0 | 0.5 | |
| Total Operating Expenses | 249.5 | 260.4 | 110.5 | 1.7 | 173.7 | 166.7 | 168.4 | 144.9 | 41.5 | 25.1 | 15.6 | |
| Operating Income | -270.4 | -281.4 | -241.4 | -195.0 | -163.8 | -164.2 | -168.1 | -137.9 | -57.5 | -23.4 | -14.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 25.2 | 37.2 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.0 | 10.6 | ||
| Depreciation & Amortization | 0.0 | 3.4 | 4.3 | 2.3 | 2.1 | 1.9 | 4.2 | 1.8 | 1.8 | 1.4 | ||
| Total Operating Expenses | 71.3 | 64.2 | 57.7 | 56.3 | 103.2 | 67.7 | 58.9 | 47.0 | 39.1 | 47.8 | ||
| Operating Income | -72.4 | -71.6 | -61.2 | -65.2 | -241.4 | -68.9 | -58.9 | -38.8 | -40.9 | -48.2 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 22.6 | 19.0 | 32.4 | 13.5 | 1.7 | 0.3 | 0.5 | 2.5 | 4.1 | 0.1 | 0.1 | |
| Interest Expense | 43.5 | 36.8 | 9.3 | 45.1 | 8.9 | 1.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | -15.0 | -15.4 | 22.3 | -13.4 | -9.4 | -1.8 | 1.9 | -1.1 | 4.0 | 0.0 | 0.0 | |
| IBT | -285.4 | -296.8 | -219.1 | -208.4 | -173.2 | -166.0 | -166.3 | -139.0 | -36.3 | -23.4 | -14.3 | |
| Income Tax Expense | 2.0 | -8.6 | 1.5 | 0.0 | -24.4 | -23.9 | -24.2 | -15.2 | -5.2 | -3.7 | -1.8 | |
| Net Income | -287.4 | -287.5 | -220.7 | -208.4 | -148.8 | -142.1 | -142.1 | -123.8 | -31.1 | -19.7 | -12.6 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 4.4 | 12.1 | 6.1 | 7.4 | 8.3 | 9.7 | 6.9 | 3.0 | 3.6 | ||
| Interest Expense | 22.8 | 10.5 | 0.0 | 10.1 | -30.8 | 10.7 | 10.2 | 19.3 | 30.1 | 5.0 | ||
| Other Expense | -19.0 | -7.0 | 13.7 | -2.7 | 215.3 | -13.2 | 0.7 | -13.9 | -23.9 | -2.6 | ||
| IBT | -91.4 | -78.6 | -47.5 | -67.9 | -26.1 | -82.1 | -58.2 | -52.7 | -64.8 | -50.8 | ||
| Income Tax Expense | -1.2 | 0.5 | 0.4 | 2.2 | 1.5 | 0.0 | 0.1 | 0.0 | 12.4 | -4.9 | ||
| Net Income | -90.2 | -79.1 | -47.9 | -70.2 | -27.6 | -82.1 | -58.3 | -52.7 | -77.2 | -45.8 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-1.20 | $-1.57 | $-1.97 | $-2.76 | $-2.88 | $-0.99 | $-1.43 | $-0.91 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-1.20 | $-1.57 | $-1.97 | $-2.76 | $-2.88 | $-0.99 | $-1.43 | $-0.91 | |
| Shares Outstanding | 266.1 | 266.1 | 255.2 | 173.9 | 95.0 | 72.1 | 51.6 | 43.1 | 31.6 | 13.8 | 13.8 | |
| Diluted Shares Outstanding | 266.1 | 266.1 | 255.2 | 173.9 | 95.0 | 72.1 | 51.6 | 43.1 | 31.6 | 13.8 | 13.8 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.44 | $-0.26 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.44 | $-0.26 | ||
| Shares Outstanding | 266.1 | 266.1 | 266.1 | 266.1 | 266.1 | 266.1 | 266.0 | 222.2 | 174.0 | 174.0 | ||
| Diluted Shares Outstanding | 266.1 | 266.1 | 266.1 | 266.1 | 266.1 | 266.1 | 266.0 | 222.2 | 174.0 | 174.0 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 707.0 | 227.4 | 239.6 | 382.4 | 310.3 | 153.3 | 210.6 | 189.3 | 137.1 | 28.1 | |
| Short Term Investments | 0.0 | 360.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 707.0 | 588.0 | 239.6 | 382.4 | 310.3 | 153.3 | 210.6 | 189.3 | 137.1 | 28.1 | |
| Accounts Receivable | 37.1 | 48.2 | 1.0 | 29.0 | 26.3 | 29.7 | 30.5 | 6.8 | 4.7 | 2.2 | |
| Inventory | 0.0 | 4.1 | 0.0 | 14.2 | 10.1 | -29.7 | 7.8 | 2.2 | 0.0 | 0.0 | |
| Other Current Assets | 12.8 | 20.5 | 34.7 | 0.2 | 0.2 | 43.7 | 0.3 | 0.7 | 0.7 | 0.7 | |
| Total Current Assets | 756.8 | 660.9 | 275.3 | 425.8 | 347.0 | 197.0 | 249.3 | 199.1 | 142.5 | 30.9 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 86.1 | 123.8 | 95.8 | 227.4 | 657.1 | 707.0 | 759.5 | 239.6 | 256.4 | 307.5 | |
| Short Term Investments | 281.3 | 330.5 | 420.8 | 360.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 367.4 | 454.3 | 516.6 | 588.0 | 657.1 | 707.0 | 759.5 | 239.6 | 256.4 | 307.5 | |
| Accounts Receivable | 91.4 | 78.6 | 14.3 | 48.2 | 1.0 | 37.1 | 31.0 | 1.0 | 42.0 | 38.2 | |
| Inventory | 27.7 | 23.9 | 14.6 | 4.1 | 0.0 | 0.0 | 0.0 | -24.5 | 9.9 | 9.6 | |
| Other Current Assets | 28.1 | 17.4 | 70.2 | 20.5 | 60.1 | 12.8 | 12.1 | 34.7 | 10.0 | 9.6 | |
| Total Current Assets | 514.6 | 574.3 | 615.8 | 660.9 | 718.1 | 756.8 | 802.6 | 275.3 | 308.4 | 355.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 90.5 | 105.1 | 95.7 | 58.4 | 52.3 | 89.7 | 51.6 | 9.2 | 6.2 | 3.3 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 12.4 | 0.0 | 0.0 | 0.1 | 0.2 | 0.3 | 9.3 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 3.0 | 1.1 | 1.4 | 4.0 | 4.4 | 5.7 | 2.0 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 96.8 | 121.8 | 100.1 | 64.5 | 58.6 | 97.3 | 54.3 | 18.5 | 6.2 | 3.3 | |
| Total Assets | 853.6 | 782.7 | 375.4 | 490.3 | 405.6 | 294.2 | 303.5 | 217.7 | 148.7 | 34.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 123.5 | 125.1 | 114.2 | 105.1 | 104.8 | 90.5 | 92.5 | 95.7 | 94.0 | 91.1 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 20.3 | 12.9 | 12.5 | 12.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 1.2 | 6.3 | 1.1 | 1.1 | 4.6 | 3.0 | 3.0 | 1.4 | 1.1 | 2.2 | |
| Total Long-Term Assets | 147.4 | 146.7 | 130.6 | 121.8 | 109.4 | 96.8 | 98.8 | 100.1 | 97.7 | 95.6 | |
| Total Assets | 661.9 | 721.0 | 746.3 | 782.7 | 827.5 | 853.6 | 901.4 | 375.4 | 406.1 | 451.0 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.1 | 2.0 | 0.1 | 0.5 | 0.4 | 2.3 | 1.1 | 12.5 | 1.9 | 1.4 | |
| Short-Term Debt | 4.2 | 3.0 | 10.1 | 5.0 | 4.5 | 3.6 | 2.5 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 35.6 | 52.2 | 34.5 | 40.8 | 0.2 | 0.5 | 0.7 | 0.0 | 3.1 | 1.3 | |
| Current Liabilities | 40.9 | 60.7 | 44.7 | 46.4 | 28.6 | 33.6 | 25.0 | 12.5 | 5.0 | 2.7 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 11.0 | 5.4 | 4.5 | 2.0 | 1.4 | 1.1 | 1.4 | 0.1 | 0.7 | 3.9 | |
| Short-Term Debt | 4.8 | 3.3 | 3.0 | 3.0 | 3.6 | 4.2 | 4.8 | 10.1 | 11.0 | 6.2 | |
| Other Current Liabilities | 55.5 | 53.1 | 50.8 | 52.2 | 47.5 | 35.6 | 37.8 | 34.5 | 25.9 | 31.0 | |
| Current Liabilities | 83.1 | 68.2 | 66.6 | 60.7 | 52.5 | 40.9 | 44.0 | 44.7 | 37.5 | 41.1 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 238.7 | 49.6 | 47.9 | 19.2 | 16.5 | 50.6 | 23.7 | 0.2 | 0.3 | 0.2 | |
| Capital Leases | 45.8 | 52.6 | 53.0 | 24.3 | 21.0 | 54.2 | 26.2 | 0.2 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 325.8 | 355.4 | 263.9 | 191.6 | 92.2 | 84.2 | 48.7 | 12.5 | 6.1 | 3.5 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 61.0 | 61.3 | 308.2 | 49.6 | 297.6 | 284.5 | 275.0 | 47.9 | 47.0 | 44.7 | |
| Capital Leases | 65.8 | 64.5 | 57.7 | 52.6 | 52.2 | 45.8 | 46.5 | 47.9 | 52.5 | 50.9 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 396.5 | 374.5 | 375.2 | 355.4 | 350.5 | 325.8 | 319.4 | 263.9 | 225.6 | 221.7 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -989.5 | -1,099.2 | -878.6 | -670.2 | -521.3 | -379.2 | -237.2 | 163.8 | -47.9 | -28.2 | |
| Comprehensive Income | -27.9 | -29.2 | -29.0 | -38.9 | -8.6 | -5.9 | -8.7 | -76.3 | -3.8 | -4.7 | |
| Total Common Equity | 527.8 | 427.3 | 111.5 | 298.7 | 313.3 | 210.0 | 254.8 | 205.1 | 142.6 | 30.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,296.4 | -1,217.3 | -1,169.4 | -1,099.2 | -1,071.6 | -989.5 | -931.3 | -878.6 | -801.4 | -755.5 | |
| Comprehensive Income | -4.9 | 0.9 | -18.1 | -29.2 | -0.8 | -27.9 | -28.9 | -29.0 | -33.8 | -28.0 | |
| Total Common Equity | 265.5 | 346.5 | 371.1 | 427.3 | 477.0 | 527.8 | 582.0 | 111.5 | 180.5 | 229.3 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 288.7 | 52.6 | 53.0 | 24.3 | 21.0 | 54.2 | 26.2 | 0.2 | 0.3 | 0.2 | |
| Book Value | 527.8 | 427.3 | 111.5 | 298.7 | 313.3 | 210.0 | 254.8 | 205.1 | 142.6 | 30.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 265.5 | 346.5 | 371.1 | 427.3 | 477.0 | 527.8 | 582.0 | 111.5 | 180.5 | 229.3 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -234.0 | -287.5 | -220.7 | -208.4 | -148.8 | -142.1 | -142.1 | -123.8 | -31.1 | -19.7 | -12.6 | |
| Depreciation & Amortization | 6.9 | 9.8 | 7.7 | 6.6 | 7.4 | 8.5 | 5.7 | 4.6 | 1.1 | 1.0 | 0.5 | |
| Stock-Based Compensation | 11.4 | 14.4 | 15.5 | 11.2 | 12.0 | 9.9 | 20.1 | 30.2 | 5.0 | 3.2 | 2.3 | |
| Change Working Capital | -11.5 | -52.1 | -23.7 | 0.3 | 4.0 | 4.1 | 1.4 | -16.2 | 5.4 | -0.8 | -1.2 | |
| Change In Accounts Receivable | 0.0 | -24.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -2.8 | 1.3 | 1.6 | -0.5 | 0.0 | -1.8 | 1.4 | -1.5 | 8.7 | 0.4 | 0.5 | |
| Change In Inventories | 0.0 | -40.3 | -4.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 83.1 | 32.1 | 15.0 | 45.7 | 13.4 | 1.8 | -1.5 | 4.1 | -1.1 | 0.0 | 1.2 | |
| Cash from Operations | -156.6 | 0.0 | 0.0 | -145.6 | -112.3 | -117.9 | -117.8 | -101.5 | -25.8 | -16.4 | -9.8 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -90.3 | -79.1 | -47.9 | -70.2 | -27.6 | -82.1 | -58.3 | -52.7 | -77.2 | -45.8 | |
| Depreciation & Amortization | 4.6 | 0.6 | 4.3 | 2.3 | 2.1 | 1.9 | 4.2 | 1.8 | 1.8 | 1.4 | |
| Stock-Based Compensation | 3.4 | 3.8 | 4.3 | 2.9 | 6.2 | 4.0 | 2.9 | 2.3 | 3.3 | 2.9 | |
| Change Working Capital | 1.1 | 40.6 | -22.9 | -17.7 | -3.0 | 2.0 | -8.9 | -13.8 | 20.8 | -9.7 | |
| Change In Accounts Receivable | 8.6 | -6.0 | -12.4 | -14.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | -7.5 | 5.4 | 1.5 | 1.9 | 0.3 | 0.3 | -0.3 | 1.3 | -0.6 | -3.2 | |
| Change In Inventories | 0.0 | 29.1 | -11.4 | -10.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | 15.1 | -33.8 | -10.9 | 6.7 | -15.8 | -2.4 | 8.9 | 22.1 | 26.9 | 11.3 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -24.8 | -40.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -4.3 | 0.0 | -22.1 | -11.0 | -10.8 | -8.9 | -14.7 | -18.7 | -8.8 | -2.9 | -1.9 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | -242.6 | -359.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 428.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -11.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 0.0 | 0.0 | |
| Cash from Investing | -4.3 | 0.0 | 0.0 | -11.0 | -10.8 | -8.9 | -14.7 | -18.7 | -7.6 | -2.9 | -1.9 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -23.8 | 15.5 | -7.3 | -8.2 | -11.1 | -9.6 | -0.8 | -0.5 | -1.5 | -1.5 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | -40.4 | -82.9 | -48.0 | -71.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 126.0 | 131.0 | 151.2 | 20.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.5 | -1.5 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -39.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 276.8 | 52.6 | -0.3 | 28.7 | 3.3 | -33.2 | 27.9 | 26.0 | 0.0 | 0.1 | 0.2 | |
| Issuance of Common Stock | 521.1 | 0.0 | 0.0 | -0.9 | 163.9 | 245.9 | 0.0 | 0.0 | 128.7 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 9.0 | 0.0 | 0.0 | -0.9 | 59.8 | 38.2 | 74.4 | 108.9 | -11.2 | 127.7 | 32.2 | |
| Cash from Financing | 559.4 | 0.0 | 0.0 | -0.9 | 223.6 | 284.1 | 74.4 | 108.9 | 117.5 | 127.7 | 32.2 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 65.8 | 1.3 | -246.6 | 258.5 | -248.5 | 12.5 | 8.9 | 226.9 | 0.5 | 1.5 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 398.4 | -123.2 | -11.5 | -142.4 | 72.1 | 156.6 | -57.3 | -6.1 | 87.0 | 109.0 | 17.9 | |
| Closing Cash Balance | 707.0 | 105.6 | 228.8 | 240.3 | 382.8 | 310.7 | 154.1 | 211.4 | 189.3 | 137.1 | 28.1 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 18.0 | -37.7 | 28.1 | -131.6 | -429.7 | -48.4 | -52.6 | 519.2 | -17.3 | -51.0 | |
| Closing Cash Balance | 105.6 | 87.6 | 125.3 | 97.3 | 228.8 | 658.5 | 707.0 | 759.5 | 239.6 | 256.8 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -161.0 | -303.3 | -241.1 | -156.6 | -123.1 | -126.7 | -132.4 | -120.2 | -34.6 | -19.2 | -11.7 | |
| Real Free Cash Flow | -172.3 | -317.8 | -256.6 | -167.8 | -135.2 | -136.7 | -152.5 | -150.4 | -39.6 | -22.4 | -14.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -91.1 | -52.4 | -80.1 | -83.8 | -61.8 | -86.3 | -51.9 | -41.0 | -26.3 | -41.7 | |
| Real Free Cash Flow | -94.5 | -56.2 | -84.4 | -86.7 | -68.0 | -90.3 | -54.9 | -43.3 | -29.6 | -44.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -1.3 | -5.1 | -1.4 |
| P/S | 4.8 | 102.6 | 9.4 |
| P/B | 1.4 | 1.7 | 5.2 |
| P/FCF | -1.1 | -4.4 | -1.5 |
| Market cap | $0.4 | $0.7 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 9.9 % | 9.9 % | 0 % |
| Debt to Income | -22.9 % | -29.7 % | 0 % |
| Debt to Free cash flow | -20.5 % | -445.7 % | 0 % |
| Interest expense percentage | -16.1 % | -5.4 % | 44.7 % |
| Current ratio | 6.2 | 9.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -108.3 % | -57.1 % | 0 % |
| ROA | -43.4 % | -35.3 % | 0 % |
| CapEx to Revenue | 21.7 % | -244.4 % | 0 % |
| RaD to Revenue | 0 % | -2536.1 % | 0 % |
| ROEM | 116,465.1 | 5815.1 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | -309.4 % | 3075.1 % | 68.7 % |
| Operating margin | -859.6 % | 3038.8 % | 35.5 % |
| Net margin | -439.7 % | 2471.8 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 266.1 mil | 118.8 mil |
| Employee count | 0.6 tis | 0.4 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
